BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34573396)

  • 21. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
    Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
    Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contiguous haemangioblastomas of the brain and spine in a patient of Von Hippel-Lindau disease.
    Rahman A; Hoque SU; Bhandari PB; Alam S
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23345492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.
    Cingoz S; van der Luijt RB; Kurt E; Apaydin M; Akkol I; Ozgen MH
    Fam Cancer; 2013 Mar; 12(1):111-7. PubMed ID: 23224817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
    Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L
    Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of von Hippel-Lindau disease in hemangioblastoma patients: the University of Tokyo Hospital experience from 1954-1998.
    Sora S; Ueki K; Saito N; Kawahara N; Shitara N; Kirino T
    Acta Neurochir (Wien); 2001 Sep; 143(9):893-6. PubMed ID: 11685621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease.
    Niemelä M; Lemeta S; Summanen P; Böhling T; Sainio M; Kere J; Poussa K; Sankila R; Haapasalo H; Kääriäinen H; Pukkala E; Jääskeläinen J
    Acta Neurochir (Wien); 1999; 141(11):1147-56. PubMed ID: 10592114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and molecular genetics of Von Hippel-Lindau disease.
    Maher ER; Webster AR; Moore AT
    Ophthalmic Genet; 1995 Sep; 16(3):79-84. PubMed ID: 8556282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
    Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
    J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients.
    Peng X; Chen J; Wang J; Peng S; Liu S; Ma K; Zhou J; Hong B; Zhou B; Zhang J; Cai L; Gong K
    J Med Genet; 2019 Jun; 56(6):380-387. PubMed ID: 30745424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
    Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
    J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal haemangioblastoma presenting as phaeochromocytoma: a rare manifestation of extraneural hemangioblastoma.
    Deb P; Pal S; Dutta V; Srivastava A; Bhargava A; Yadav KK
    Endocr Pathol; 2012 Sep; 23(3):187-90. PubMed ID: 22544391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Von Hippel-Lindau disease: delayed presentation as a cerebellar haemangioblastoma in an elderly patient.
    Shekhar H; Myles L; Lee M
    Br J Neurosurg; 2009 Feb; 23(1):97-8. PubMed ID: 19234919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial and genetic researches on three Chinese families with von Hippel-Lindau disease.
    Mao XC; Su ZP; Yu WQ; Zheng WM; Zeng YJ
    Neurol Res; 2009 Sep; 31(7):743-7. PubMed ID: 19133167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
    Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
    Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
    Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
    BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetic analysis of von Hippel-Lindau disease.
    Richards FM; Webster AR; McMahon R; Woodward ER; Rose S; Maher ER
    J Intern Med; 1998 Jun; 243(6):527-33. PubMed ID: 9681854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive characterization and building of National Registry of von Hippel-Lindau disease in Brazil.
    Dallagnol TN; Da Cás E; Junior OR; Casali-da-Rocha JC
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2136. PubMed ID: 36625343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.